Zobrazeno 1 - 10
of 22
pro vyhledávání: '"V N Shchukina"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 65, Iss 3-4, Pp 3-6 (2020)
The antiviral activity of the drug Kagocel®, which has a high safety profile and proven efficacy for the prevention and treatment of influenza and AVRI as an interferon inducer, was studied against a new pandemic strain of SARS-CoV-2 in vitro in Ver
Externí odkaz:
https://doaj.org/article/30b72c822a4f45a9ae82509d63112cc9
Publikováno v:
Антибиотики и Химиотерапия, Vol 65, Iss 3-4, Pp 45-53 (2020)
The Chikungunya virus (CHIKV) is an alphavirus transmitted to people by Aedes mosquitoes, usually Aedes aegypti and Aedes albopictus. The virus causes Chikungunya fever, a disease characterized by fever, nausea, headaches, rash, and persistent arthra
Externí odkaz:
https://doaj.org/article/86151e27a8bc4754a199b73cd8123cd7
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 7-8, Pp 42-46 (2020)
Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory.
Externí odkaz:
https://doaj.org/article/0c16e8d1224f4af6985ee82061cf6e23
Autor:
S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, G. V. Borisevich, V. P. Bondarev, V. A. Shevtsov
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 5-6, Pp 7-10 (2020)
Analysis of the efficacy of Grippferon vs. the reference drugs Realdiron and Reaferon-EC against the influenza virus A(H1N1)/2009 in susceptible static cell cultures showed that in the concentrations tested it was efficient in inhibition of the virus
Externí odkaz:
https://doaj.org/article/66b6ace5dd4f450786ca49dc43012a8a
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 9-10, Pp 41-46 (2020)
The results of the in vitro studies on the efficacy of medical nonspecific protective agents from various pharmacological groups showed that some drugs, such as velferon, alferon, betaferon, ribavirin and lopinavir were active against TOPC virus, tha
Externí odkaz:
https://doaj.org/article/6d545b51da194f9482f19949395c7caa
Autor:
S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, M. V. Lykov, G. V. Borisevich, V. P. Bondarev, V. E. Nebolsin, O. A. Sutochnikova, A. G. Chychalin
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 11-12, Pp 17-21 (2020)
High in vitro and in vivo efficacy of Ingavirin® against the Mexican pandemic influenza virus A/H1N1/2009, strains A/California/ 04/2009 (H1N1) and A/California/07/2009 (H1N1) vs. the reference drug Arbidol® was studied and verified when used thera
Externí odkaz:
https://doaj.org/article/76fa6a90c064433cab7ae2246e1d2993
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 5-6, Pp 13-17 (2020)
Studies have been carried out to study the effectiveness of the high-molecular inducer of interferon Larifan® in relation to the experimental form of severe acute respiratory syndrome in Syrian hamsters. It is shown that Lariphan® is effective when
Externí odkaz:
https://doaj.org/article/8026da02ebb744f0826150edbe1b8251
Publikováno v:
Антибиотики и Химиотерапия, Vol 63, Iss 11-12, Pp 3-7 (2020)
Studies have shown that high-molecular inducers of interferon Larigan®, Ridostin®, and Rifastin cause «early» interferon production which amounts to maximum 3 hours after injection. Re-introduction of interferon inducers with an interval of 3 day
Externí odkaz:
https://doaj.org/article/ef3dcc68fbbe46ca8581a29edc793544
Autor:
S. Ya. Loginova, V. N. Shchukina, S. V. Borisevich, R. A. Khamitov, V. A. Maksimov, A. M. Shuster
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 7-8, Pp 19-23 (2020)
Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden hamster. It is shown that Arbidol® is most effective when used in therapeutic and prophyl
Externí odkaz:
https://doaj.org/article/2e5ce733f52c4069be1a069cf5b95ef6
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 11-12, Pp 31-34 (2020)
Studies have been carried out on the effectiveness of the high molecular weight interferon inducer Ridostin® in relation to the experimental form of severe acute respiratory syndrome in Syrian hamsters. It is shown that Ridostin® is effective when
Externí odkaz:
https://doaj.org/article/ccecb7d5869642b9b35f89d86b41d14e